Cargando…

Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections

INTRODUCTION: Ca-125 is secreted by different celomic epitheliums. Serum levels may be increased in malignant diseases, like ovarian cancer but also in other medical conditions, such as pulmonary and extrapulmonary tuberculosis. METHODS: From Jan-04 to Dec-06 a retrospective study analyzing Ca-125 l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortún, J, Martín-Dávila, P, Méndez, R, Martínez, A, Norman, F, Rubi, J, Pallares, E, Gómez-Mampaso, E, Moreno, S
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788741/ https://www.ncbi.nlm.nih.gov/pubmed/19966922 http://dx.doi.org/10.2174/1874306400903010123

Ejemplares similares

The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995–2013)
por: González-García, Andrés, et al.
Publicado: (2017)

The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis
por: Tascı, Canturk, et al.
Publicado: (2012)

Hematological Parameters as Potential Markers for Distinguishing Pulmonary Tuberculosis from Genitourinary Tuberculosis
por: Tu, Hui-Zin, et al.
Publicado: (2023)

LETTER TO THE EDITOR: Is the Determination of CA-125 Serum Levels Useful for the Diagnosis of Pulmonary Tuberculosis?
por: Collazos, Julio
Publicado: (2010)

Serum CA-125 for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis
por: Zhao, Ping, et al.
Publicado: (2021)

A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis
por: Liang, Qiang, et al.
Publicado: (2023)

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
por: Bloom, Chloe I., et al.
Publicado: (2013)

CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis
por: Wani, Abdul Majid, et al.
Publicado: (2008)

Oncological markers CA-125, CA 19-9 and endometriosis
por: Fiala, Ludek, et al.
Publicado: (2018)

Correction: Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
por: Bloom, Chloe I., et al.
Publicado: (2013)

A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children
por: Togun, Toyin, et al.
Publicado: (2020)

CA-125 is not a useful marker in metastatic breast cancer.
por: Seckl, M. J., et al.
Publicado: (1992)

Red blood cell distribution width and serum CA-125 level as prognostic markers in acute exacerbation of chronic obstructive pulmonary disease
por: He, Fang, et al.
Publicado: (2021)

Identification of autoimmune markers in pulmonary tuberculosis
por: Starshinova, Anna, et al.
Publicado: (2023)

Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
por: Xie, Wen ting, et al.
Publicado: (2022)

Peritoneal and Pulmonary Tuberculosis in a Postpartum Female with Elevated Cancer Antigen 125 and Ascites
por: Lavrynenko, Olga, et al.
Publicado: (2022)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.
por: Heikinheimo, M., et al.
Publicado: (1990)

Peritoneal trauma releases CA125?
por: Redman, C. W., et al.
Publicado: (1988)

Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis
por: Muller, Beatriz Lima Alezio, et al.
Publicado: (2013)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Using artificial intelligence to assist radiologists in distinguishing COVID-19 from other pulmonary infections
por: Yang, Yanhong, et al.
Publicado: (2021)

Pulmonary Tuberculosis
por: Trajman, Anete, et al.
Publicado: (2013)

Peritoneal Tuberculosis With Raised Cancer Antigen 125 (CA-125) in a Post-partum Woman: A Case Report
por: Mahajan, Mayank, et al.
Publicado: (2023)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans
por: Collins, Jeffrey M., et al.
Publicado: (2018)

CA125 effects on humoral immunosuppression
por: Kline, J. Bradford, et al.
Publicado: (2017)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)

Lung tumour markers in oncology practice: a study of TPA and CA125
por: Buccheri, G, et al.
Publicado: (2002)

The effect of CA125 on metastasis of ovarian cancer: old marker new function
por: Yuan, Qin, et al.
Publicado: (2017)

Comparison of Ultrasound and Tumor Marker CA125 in Diagnosis of Adnexal Mass Malignancies
por: Behnamfar, Fariba, et al.
Publicado: (2022)

Role of CA-125 Level as a Marker in the Management of Severe Pre-Eclampsia
por: Balint, Oana, et al.
Publicado: (2022)

Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas
por: Napoli, Niccolò, et al.
Publicado: (2023)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

The Treatment of Pulmonary Tuberculosis by Artificial Pneumothorax and Other Methods of Collapse
por: Dunlop, D. Melville, et al.
Publicado: (1934)

Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis?
por: Kiran, Bayram, et al.
Publicado: (2010)

Label-Free Quantitative Proteomics Identifies Novel Plasma Biomarkers for Distinguishing Pulmonary Tuberculosis and Latent Infection
por: Sun, Huishan, et al.
Publicado: (2018)

Treatment of Pulmonary Tuberculosis
por: Thrash, E. C.
Publicado: (1915)

CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis
por: Bulska-Będkowska, Weronika, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mbm99so9t6rrdls25pi6ber316